Needham & Company LLC Reiterates Hold Rating for Intra-Cellular Therapies (NASDAQ:ITCI)
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “hold” rating reissued by equities research analysts at Needham & Company LLC in a research note issued on Friday,Benzinga reports. Several other research firms also recently weighed in on ITCI. JPMorgan Chase & Co. increased their price target on shares of Intra-Cellular Therapies from $81.00 […]
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report)‘s stock had its “hold” rating reissued by equities research analysts at Needham & Company LLC in a research note issued on Friday,Benzinga reports. Several other research firms also recently weighed in on ITCI. JPMorgan Chase & Co. increased their price target on shares of Intra-Cellular Therapies from $81.00 […]
